Trade Summary

4 days ago, Ali-Jackson Kamil, serving as Dir at RIGEL PHARMACEUTICALS INC (RIGL), sold 2,500 shares at $35.00 per share, for a total transaction value of $87,500.00. Following this transaction, Ali-Jackson Kamil now holds 10,125 shares of RIGL.

This sale represents a 19.80% decrease in Ali-Jackson Kamil's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 4:04 PM ET, 2 days after the trade was made.

RIGEL PHARMACEUTICALS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.